Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.

Clinical trial NCT05291039 · COMPLETED

Trial details

NCT number: NCT05291039
Sponsor: Rehab Werida
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2022-01-01
Primary completion: 2023-03-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.